This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Baird S. Grimson, MD; Zebulon L. Bowman, MD

Arch Ophthalmol. 1983;101(4):604-606.

Abstract
• Bromocriptine mesylate (2-bromo--ergocryptine) has proved to be useful in reducing the size of prolactin-secreting pituitary adenomas, but little evidence has accumulated about its effectiveness within the first two weeks of therapy. The patient described herein showed a rapid reduction in the size of the suprasellar extension of a prolactinoma and a dramatic improvement of the primary visual field abnormalities within two weeks of starting bromocriptine therapy. This experience exemplifies the potential use of the drug in acutely decompressing the anterior intracranial visual pathways.

Author Affiliations
From the Department of Ophthalmology, University of North Carolina School of Medicine, Chapel Hill.

Footnotes
Accepted for publication April 20, 1982.

Reprint requests to Department of Ophthalmology, 617 Clinical Sciences Bldg (229 H), University of North Carolina, Chapel Hill, NC 27514 (Dr Grimson).

Cheryl A. Viglione, MD, assisted in the interpretation of the roentgenograms.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Malignant Glioma of the Optic Chiasm Eight Years After Radiotherapy for Prolactinoma
Hufnagel et al.
Arch Ophthalmol 1988;106:1701-1705.
ABSTRACT